New York City Residents Take Steps to End Lung Cancer and Lung Disease at LUNG FORCE Walk on May 13

American Lung Association event to fund lifesaving lung cancer and other chronic lung disease research.
Lung cancer is the leading cause of cancer deaths in the U.S. and nearly 34 million Americans live with lung disease, but the American Lung Association is working toward a future free of lung cancer, asthma, COPD and other chronic lung diseases disease. In an effort to end lung disease, the American Lung Association LUNG FORCE Walk will take place at Manhattan’s South Street Seaport on May 13, 2023 at 9:30 am.

The LUNG FORCE Walk is a celebratory and welcoming event that provides critical funds for lifesaving lung cancer and lung disease research, early detection initiatives and awareness.  

“More than 34 million Americans live with a chronic lung disease like asthma and COPD – and lung cancer remains the leading cause of cancer deaths among people in the U.S., but here is hope. Communities everywhere are coming together to push for more research, more treatment options and more support for those impacted by lung diseases,” said Erica Masin, Executive Director at the Lung Association in metro New York. “On May 13, hundreds of New Yorkers will turnout to the South Street Seaport to raise awareness about lung cancer, lighten the burden for people living with lung disease, honor the memory of those we’ve lost and lift up those who need our love.”

The LUNG FORCE Walk is great for friends, family and companies to come together to support people with lung disease and lung cancer, have fun and get some great exercise. Joining the LUNG FORCE Walk supports the work of the American Lung Association to defeat lung cancer, improve the air we breathe, reduce the burden of lung disease on individuals and their families, and eliminate tobacco use and tobacco-related diseases.

Arunesh Verma, CEO, Cipla USA said, “Cipla USA is proud to partner with the American Lung Association for the LUNG FORCE Walk NYC. Our expertise in respiratory health has helped us launch several pioneering innovations to help millions around the world to breathe free. Guided by our purpose of 'Caring for Life' we are committed to support initiatives that help raise awareness and enhance access to high-quality treatments for patients with lung ailments/diseases. Together, we can make a difference in the lives of patients by bringing respiratory care closer to them.”

Cipla is a Silver Sponsor for this year’s  LUNG FORCE Walk New York City.  Other local sponsors include Sanofi, and Mount Sinai The Tisch Cancer Institute.
 
For more information and to register for the LUNG FORCE Walk New York City, visit LUNGFORCE.org/nyc


About Cipla
Established in 1935, Cipla is a global pharmaceutical company focused on agile and sustainable growth, complex generics, and deepening its portfolio in our home markets of India, South Africa, North America, and key regulated and emerging markets. Our strengths in the respiratory, anti-retroviral, urology, cardiology, anti-infective and CNS segments are well-known. Our 47 manufacturing sites around the world produce 50+ dosage forms and 1,500+ products using cutting-edge technology platforms to cater to our 86 markets. Cipla is the 3rd largest in pharma in India (IQVIA MAT March’ 23), 3rd largest in the pharma private market in South Africa (IQVIA MAT March’ 23), and is among the top 10 generic players in the U.S. Cipla USA, the wholly owned subsidiary of Cipla has been enabling access to affordable medicines in the US for over 30 years and is poised to continue its mission of making high-quality medicines accessible to patients in the US. As pioneers in inhalation therapy/respiratory care, Cipla ranks no. 2 in inhaler sales globally and ranks in the top 3 for US generic respiratory sales. A responsible corporate citizen, Cipla’s humanitarian approach to healthcare in pursuit of its purpose of ‘Caring for Life’ and deep-rooted community links wherever it is present make it a partner of choice to global health bodies, peers, and all stakeholders. For more information, please visit www.ciplausa.com
 
For more information, contact:

Jennifer Solomon
(516) 680-8927
[email protected]

Freedom From Smoking Clinic
Detroit, MI | May 29, 2024
Asthma Basics Workshop - National
, | Jun 18, 2024